Furthermore, in a cohort of 2025 patients from the Framingham Heart study, elevated plasma Gal-3 was associated with restrictive lung disease, decreased lung volumes and altered gas exchange (Ho et al., 2016), suggesting a potential role for Gal-3 in the early stages of pulmonary fibrosis. This evidence concerns the gene LGALS3 and pulmonary fibrosis.